Page 295 - Syndipharma

Type Product Dosage Form Strength Indication Status

Antimalarial Chloroquine phosphate Tablet 200 mg Antimalarial In market
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Bronchodilator
and Anti-asth- Salbutamol Syrup 2mg/5 ml Beta 2 Agonist In market
ma Drugs
Bronchodilator Theophylline/ Guaifen- Syrup (50/30mg)/5ml Xanthine Derivatives - Mu- In market
and Expectorant esin colytic

Atorvastatin Tablet 20,40 mg Statin In market

Rivaroxaban Tablet 15, 20 mg Statin Coming soon
Cardiovascular
System
Fenofibrate Capsule 200 mg Fibric Acid agent Coming soon

Rosuvastatin Tablet 5,10,20 mg Statin In market

Duloxetine Capsule 30,60 mg SNRI In market

Clonazepam Tablet 1,2 mg Benzodiazepine In market

Venlafaxin ER Capsule 75 mg SNRI Coming soon

Perphenazine Tablet 2,4,8 mg Antipsychotic - 1 generation In market
st

Pregabalin Capsule 75 mg Anticonvulsant Coming soon
Central Nervous
System
Diazepam syrup 2mg/5ml Benzodiazepine In market

Dapoxetin Tablet 30 mg Anti-Depressant Coming soon

Thioridazine Tablet 10,25,100 mg Anti-Psychotic In market

Phenobarbital Tablet 60,100 mg Anticonvulsant In market

Sumatriptan Tablet 50 mg Serotonin Agonist In market

Dextromethorphan - P Syrup (15/30) mg/5 ml Decongestant In market

Cough Suppres-
sants Dextromethorphan Syrup 15 mg/ 5 ml Antitussive In market
(analgesics,an-
tihistamines,
decongestant Acetaminophen/ Phen- Antipyretic, Alpha agonist,
and expecto- ylephrine/ Chlorpheni- Tablet (325/5/2) mg Antihistamine, Decongestant In market
rants) ramine

294
Guaifenesin Syrup 100 mg/ 5 ml Expectorant In market